Aroa Biosurgery

CompanyNew Zealand

Aroa Biosurgery develops one asset, in human trials (Symphony in diabetic foot ulcer). Mostly device; based in New Zealand.

1
Asset
Furthest stage
Human trials
0
Trials
0
Signals

Pipeline

1
  • Symphony

    Extracellular matrix scaffold device promoting soft tissue regeneration and wound closure

    Human trials, Device, diabetic foot ulcer

Full company profiles: pipeline, trials, funding and people.

See Pro

In the full profile

  • Similar companies4

Intelligence